• Je něco špatně v tomto záznamu ?

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

R. van Amerongen, M. Bentires-Alj, AL. van Boxtel, RB. Clarke, S. Fre, EG. Suarez, R. Iggo, M. Jechlinger, J. Jonkers, ML. Mikkola, ZS. Koledova, T. Sørlie, MD. Vivanco

. 2023 ; 28 (1) : 17. [pub] 20230714

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016882

On 8 December 2022 the organizing committee of the European Network for Breast Development and Cancer labs (ENBDC) held its fifth annual Think Tank meeting in Amsterdam, the Netherlands. Here, we embraced the opportunity to look back to identify the most prominent breakthroughs of the past ten years and to reflect on the main challenges that lie ahead for our field in the years to come. The outcomes of these discussions are presented in this position paper, in the hope that it will serve as a summary of the current state of affairs in mammary gland biology and breast cancer research for early career researchers and other newcomers in the field, and as inspiration for scientists and clinicians to move the field forward.

Cancer Heterogeneity Lab CIC bioGUNE Basque Research and Technology Alliance BRTA Technological Park Bizkaia 48160 Derio Spain

Cell Biology and Biophysics Department EMBL Heidelberg Germany

Department of Cancer Genetics Institute for Cancer Research Oslo University Hospital Oslo Norway

Department of Histology and Embryology Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Developmental Stem Cell and Cancer Biology Swammerdam Institute for Life Sciences University of Amsterdam Science Park 904 1098 XH Amsterdam the Netherlands

Division of Molecular Pathology Oncode Institute Netherlands Cancer Institute Plesmanlaan 121 1066CX Amsterdam The Netherlands

INSERM U1312 University of Bordeaux 33076 Bordeaux France

Institut Curie Genetics and Developmental Biology Department PSL Research University CNRS UMR3215 U93475248 InsermParis France

Institute of Biotechnology HiLIFE Helsinki Institute of Life Science University of Helsinki P O B 56 00014 Helsinki Finland

Laboratory of Tumor Heterogeneity Metastasis and Resistance Department of Biomedicine University of Basel and University Hospital of Basel Basel Switzerland

Manchester Breast Centre Division of Cancer Sciences School of Medical Sciences University of Manchester Manchester UK

Molit Institute of Personalized Medicine Heilbronn Germany

Oncobell Bellvitge Biomedical Research Institute L'Hospitalet de Llobregat Barcelona Spain

Transformation and Metastasis Laboratory Molecular Oncology Spanish National Cancer Research Centre Madrid Spain

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016882
003      
CZ-PrNML
005      
20231026105505.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10911-023-09544-y $2 doi
035    __
$a (PubMed)37450065
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a van Amerongen, Renée $u Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands. r.vanamerongen@uva.nl $1 https://orcid.org/0000000288082092
245    10
$a Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research / $c R. van Amerongen, M. Bentires-Alj, AL. van Boxtel, RB. Clarke, S. Fre, EG. Suarez, R. Iggo, M. Jechlinger, J. Jonkers, ML. Mikkola, ZS. Koledova, T. Sørlie, MD. Vivanco
520    9_
$a On 8 December 2022 the organizing committee of the European Network for Breast Development and Cancer labs (ENBDC) held its fifth annual Think Tank meeting in Amsterdam, the Netherlands. Here, we embraced the opportunity to look back to identify the most prominent breakthroughs of the past ten years and to reflect on the main challenges that lie ahead for our field in the years to come. The outcomes of these discussions are presented in this position paper, in the hope that it will serve as a summary of the current state of affairs in mammary gland biology and breast cancer research for early career researchers and other newcomers in the field, and as inspiration for scientists and clinicians to move the field forward.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a mléčné žlázy lidské $7 D042361
650    12
$a nádory prsu $7 D001943
650    _2
$a prsy $7 D001940
650    _2
$a biologie $7 D001695
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bentires-Alj, Mohamed $u Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland $1 https://orcid.org/0000000163441127
700    1_
$a van Boxtel, Antonius L $u Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands $1 https://orcid.org/0009000666493807
700    1_
$a Clarke, Robert B $u Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK $1 https://orcid.org/0000000154073123
700    1_
$a Fre, Silvia $u Institut Curie, Genetics and Developmental Biology Department, PSL Research University, CNRS UMR3215, U93475248, InsermParis, France $1 https://orcid.org/0000000272097636
700    1_
$a Suarez, Eva Gonzalez $u Transformation and Metastasis Laboratory, Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain $u Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $1 https://orcid.org/0000000308588171
700    1_
$a Iggo, Richard $u INSERM U1312, University of Bordeaux, 33076, Bordeaux, France $1 https://orcid.org/0000000288229111
700    1_
$a Jechlinger, Martin $u Cell Biology and Biophysics Department, EMBL, Heidelberg, Germany $u Molit Institute of Personalized Medicine, Heilbronn, Germany $1 https://orcid.org/0000000237104466
700    1_
$a Jonkers, Jos $u Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands $1 https://orcid.org/0000000292649792
700    1_
$a Mikkola, Marja L $u Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, P.O.B. 56, 00014, Helsinki, Finland $1 https://orcid.org/0000000298903835
700    1_
$a Koledova, Zuzana Sumbalova $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic $1 https://orcid.org/0000000293331399 $7 jx20110603007
700    1_
$a Sørlie, Therese $u Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway $1 https://orcid.org/0000000259952319
700    1_
$a Vivanco, Maria dM $u Cancer Heterogeneity Lab, CIC bioGUNE, Basque Research and Technology Alliance, BRTA, Technological Park Bizkaia, 48160, Derio, Spain $1 https://orcid.org/000000029540247X
773    0_
$w MED00007728 $t Journal of mammary gland biology and neoplasia $x 1573-7039 $g Roč. 28, č. 1 (2023), s. 17
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37450065 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105500 $b ABA008
999    __
$a ok $b bmc $g 2000421 $s 1203244
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 28 $c 1 $d 17 $e 20230714 $i 1573-7039 $m Journal of mammary gland biology and neoplasia $n J Mammary Gland Biol Neoplasia $x MED00007728
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace